Clinical Trial Update: Radioactive Iodide (131I) Treatment of 124I PET/CT Detected Breast Cancers [NA]

View source ↗

Summary

A Stanford University-sponsored trial investigating iodine-131 radiopharmaceutical therapy for breast cancers detected by 124I PET/CT has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Iodine-131 radiopharmaceutical (Iodine-131)

Snippet

Sponsor: Stanford University | Conditions: Breast Cancer, Metastatic Breast Cancer | NA | Status: WITHDRAWN